29786-44-5Relevant articles and documents
Iridium-Catalyzed Enantioselective C(sp3)–H Borylation of Cyclobutanes
Chen, Xiang,Chen, Lili,Zhao, Hongliang,Gao, Qian,Shen, Zhenlu,Xu, Senmiao
supporting information, p. 1533 - 1537 (2020/09/09)
We herein report the first example of iridium-catalyzed enantioselective C(sp3)–H borylation of cyclobutanes using benzoxazoline as the directing group. The combination of a chiral bidentate boryl ligand and an iridium precursor has found to effectively catalyze C(sp3)–H borylation to afford a variety of cyclobutylboronates with good to excellent enantioselectivities. We also demonstrate the synthetic utility of the current method by converting the stereogenic C—B bond to other functionalities.
PYRIMIDONE CARBOXAMIDE COMPOUNDS AS PDE2 INHIBITORS
-
Page/Page column 43; 44, (2015/07/15)
Disclosed are pyrimidine carboxamide compounds of formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2), pharmaceutical compositions and uses thereof.
NOVEL TRPV3 MODULATORS
-
Paragraph 1875; 1876, (2013/06/04)
Disclosed herein are modulators of TRPV3 of formula (II): wherein G1, X1, X2, X3, X4, X5, G2, Ra, Rb, and u are as defined in the specification. Composition